Literature DB >> 7681776

DNA response to bleomycin in mammalian cells with variable degrees of chromatin condensation.

D M Lopez-Larraza1, N O Bianchi.   

Abstract

BLM induces DNA degradation in living cells. We used CHO cells with maximal chromatin compactness (cells synchronized in metaphase), cells with chromatin decondensed by Na butyrate treatments, and control cells with normal chromatin condensation in order to analyse the correlation between chromatin compactness, DNA sensitivity to BLM, efficiency of repair of BLM-induced DNA lesions, and cell viability. We found that the DNA sensitivity to BLM and the efficiency of DNA repair is inversely correlated with the degree of chromatin coiling. Cells with decondensed chromatin are those showing higher DNA sensitivity to BLM but also those having the best efficiency to mend the damage. Accordingly, these cells show an amount of residual DNA lesions and a curve of growth similar to that of control cells. The situation is just the opposite for metaphase cells. The DNA of these cells is more resistant to BLM, but the damage is poorly repaired. The final result is that BLM induces a higher concentration of residual DNA lesions and a lower viability in metaphase than in control cells. Our results suggest that chromatin structure influences the quantity and reparability of the BLM-induced lesions, producing a higher incidence of double strand break in the DNA of cells with marked chromatin condensation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681776     DOI: 10.1002/em.2850210309

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  2 in total

1.  A new approach to DNA bending by polyamines and its implication in DNA condensation.

Authors:  David Pastré; Olivier Piétrement; Fabrice Landousy; Loïc Hamon; Isabelle Sorel; Marie-Odile David; Etienne Delain; Alain Zozime; Eric Le Cam
Journal:  Eur Biophys J       Date:  2005-10-25       Impact factor: 1.733

Review 2.  Chromatin as a target for the DNA-binding anticancer drugs.

Authors:  Parijat Majumder; Suman K Pradhan; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  Subcell Biochem       Date:  2007
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.